I read with interest the research report entitled "Phonophoretic Delivery of 10% Hydrocortisone Through the Epidermis of Humans as Determined by Serum Cortisol Concentrations" by Bare et a1 in the July 1996 issue of Physical Therapy. As indicated in the report regarding the results: "No rise in serum cortisol concentrations following hydrocortisone phonophoresis was detected .... These findings suggest that there was no penetration of hydrocortisone through the epidermis and into the underlying vasculature."
I have treated my own personal animals (horses) with ultrasound, using dimethyl sulfoxide (DMSO) as a coupling agent (I work only with my own animals; as far I know, the only physical therapy practice act that mentions referral from veterinarians is that of New Mexico). I've used dosages that have ranged from 0.5 to 1 W/cm2. The types of injuries have included rupture of tendons (bowed tendons) and myositis. The results have been encouraging, but have not been part of an ongoing objective study. (The use of DMSO for humans is not approved by the US Food and Drug Administration.) If physical therapy for animals ever becomes a part of every state's practice act, it would be most interesting to initiate a study of this physical therapy modality using DSMO as a coupling agent.
J F L Smith, PT 1081 1 North Circle M Ave Dunnellon, FL 32630
To the Editor: I am writing in response to the research report on phonophoresis by Bare and colleagues in the July 1996 issue.
Bare and colleagues' conclusion that there was no penetration of hydrocortisone through the epidermis and into the underlying vasculature leaves me a bit disturbed. With transdermal penetration of large complex molecules (eg, nitroglycerin, insulin)-a common procedure today-I find it unusual that with the aid of the sound wave's energy, there was no penetration. This leads me to my favorite argument: It is not the concept of phonophoresis that is in question, but rather it's the technique of administration that may be faulty.
In this study, a 10% solution of ; hydrocortisone acetate was utilized. : Why 10% hydrocortisone? We use ,
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